skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 23  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 next page
Show only
Refined by: subject: Cardiovascular Diseases remove xxx: xxx remove Diabetes remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Global Burden of Disease and Risk Factors
Global Burden of Disease and Risk Factors
Material Type:
Book 		Add to My Research

Global Burden of Disease and Risk Factors

The International Bank for Reconstruction and Development / The World Bank 2006 ;CC BY 3.0 IGO http://creativecommons.org/licenses/by/3.0/igo World Bank ;ISBN: 9780821362624 ;ISBN: 0821362623 ;EISBN: 9780821362631 ;EISBN: 0821362631 ;DOI: 10.1596/978-0-8213-6262-4 ;OCLC: 824549146

Full text available

Citations Cited by
2
Clinical effectiveness of cardiac rehabilitation and barriers to completion in patients of low socioeconomic status in rural areas: A mixed-methods study
Clinical effectiveness of cardiac rehabilitation and barriers to completion in patients of low socioeconomic status in rural areas: A mixed-methods study
Material Type:
Article 		Add to My Research

Clinical effectiveness of cardiac rehabilitation and barriers to completion in patients of low socioeconomic status in rural areas: A mixed-methods study

Clinical rehabilitation, 2024-06, Vol.38 (6), p.837-854 [Peer Reviewed Journal]

The Author(s) 2024 ;ISSN: 0269-2155 ;EISSN: 1477-0873 ;DOI: 10.1177/02692155241236998

Digital Resources/Online E-Resources

Citations Cited by
3
SGLT2 Inhibitors as a Therapeutic Option for Diabetic Nephropathy
SGLT2 Inhibitors as a Therapeutic Option for Diabetic Nephropathy
Material Type:
Article 		Add to My Research

SGLT2 Inhibitors as a Therapeutic Option for Diabetic Nephropathy

International journal of molecular sciences, 2017-05, Vol.18 (5), p.1083 [Peer Reviewed Journal]

Copyright MDPI AG 2017 ;2017 by the authors. 2017 ;ISSN: 1422-0067 ;ISSN: 1661-6596 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms18051083 ;PMID: 28524098

Full text available

Citations Cited by
4
Gut Microbiota in Hypertension and Atherosclerosis: A Review
Gut Microbiota in Hypertension and Atherosclerosis: A Review
Material Type:
Article 		Add to My Research

Gut Microbiota in Hypertension and Atherosclerosis: A Review

Nutrients, 2020-09, Vol.12 (10), p.2982 [Peer Reviewed Journal]

2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 by the authors. 2020 ;ISSN: 2072-6643 ;EISSN: 2072-6643 ;DOI: 10.3390/nu12102982 ;PMID: 33003455

Full text available

Citations Cited by
5
Elevated urine albumin creatinine ratio increases cardiovascular mortality in coronary artery disease patients with or without type 2 diabetes mellitus: a multicenter retrospective study
Elevated urine albumin creatinine ratio increases cardiovascular mortality in coronary artery disease patients with or without type 2 diabetes mellitus: a multicenter retrospective study
Material Type:
Article 		Add to My Research

Elevated urine albumin creatinine ratio increases cardiovascular mortality in coronary artery disease patients with or without type 2 diabetes mellitus: a multicenter retrospective study

Cardiovascular diabetology, 2023-08, Vol.22 (1), p.203-203, Article 203 [Peer Reviewed Journal]

2023. BioMed Central Ltd., part of Springer Nature. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;BioMed Central Ltd., part of Springer Nature 2023 ;ISSN: 1475-2840 ;EISSN: 1475-2840 ;DOI: 10.1186/s12933-023-01907-3 ;PMID: 37563647

Full text available

Citations Cited by
6
Effect of Urinary Albumin Creatinine Ratio on Cardiovascular Morbidity and Mortality in Diabetes Patients with Atherosclerotic Disease
Effect of Urinary Albumin Creatinine Ratio on Cardiovascular Morbidity and Mortality in Diabetes Patients with Atherosclerotic Disease
Material Type:
Article 		Add to My Research

Effect of Urinary Albumin Creatinine Ratio on Cardiovascular Morbidity and Mortality in Diabetes Patients with Atherosclerotic Disease

Diabetes, metabolic syndrome and obesity, 2023-01, Vol.16, p.819-828 [Peer Reviewed Journal]

2023 Gao et al. ;COPYRIGHT 2023 Dove Medical Press Limited ;2023. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 Gao et al. 2023 Gao et al. ;ISSN: 1178-7007 ;EISSN: 1178-7007 ;DOI: 10.2147/DMSO.S400970 ;PMID: 36959900

Full text available

Citations Cited by
7
Marker for kidney fibrosis is associated with inflammation and deterioration of kidney function in people with type 2 diabetes and microalbuminuria
Marker for kidney fibrosis is associated with inflammation and deterioration of kidney function in people with type 2 diabetes and microalbuminuria
Material Type:
Article 		Add to My Research

Marker for kidney fibrosis is associated with inflammation and deterioration of kidney function in people with type 2 diabetes and microalbuminuria

PloS one, 2023-03, Vol.18 (3), p.e0283296-e0283296 [Peer Reviewed Journal]

Copyright: © 2023 Poulsen et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ;COPYRIGHT 2023 Public Library of Science ;2023 Poulsen et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 Poulsen et al 2023 Poulsen et al ;2023 Poulsen et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0283296 ;PMID: 36930632

Full text available

Citations Cited by
8
Comparison of Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Prescribing in Patients With Diabetes Mellitus With and Without Cardiovascular Disease
Comparison of Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Prescribing in Patients With Diabetes Mellitus With and Without Cardiovascular Disease
Material Type:
Article 		Add to My Research

Comparison of Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Prescribing in Patients With Diabetes Mellitus With and Without Cardiovascular Disease

The American journal of cardiology, 2023-02, Vol.189, p.121-130 [Peer Reviewed Journal]

2022 Elsevier Inc. ;Copyright © 2022 Elsevier Inc. All rights reserved. ;2022. Elsevier Inc. ;ISSN: 0002-9149 ;EISSN: 1879-1913 ;DOI: 10.1016/j.amjcard.2022.10.041 ;PMID: 36424193

Full text available

Citations Cited by
9
Molecular Mechanisms of SGLT2 Inhibitor on Cardiorenal Protection
Molecular Mechanisms of SGLT2 Inhibitor on Cardiorenal Protection
Material Type:
Article 		Add to My Research

Molecular Mechanisms of SGLT2 Inhibitor on Cardiorenal Protection

International journal of molecular sciences, 2020-10, Vol.21 (21), p.7833 [Peer Reviewed Journal]

2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 by the authors. 2020 ;ISSN: 1422-0067 ;ISSN: 1661-6596 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms21217833 ;PMID: 33105763

Full text available

Citations Cited by
10
Hypertension in adults: summary of updated NICE guidance
Hypertension in adults: summary of updated NICE guidance
Material Type:
Article 		Add to My Research

Hypertension in adults: summary of updated NICE guidance

BMJ (Online), 2019-10, Vol.367, p.l5310-l5310 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go tohttp://group.bmj.com/group/rights-licensing/permissions2019BMJ ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.l5310 ;PMID: 31636059

Full text available

Citations Cited by
11
Indoxyl Sulfate Elevated Lnc-SLC15A1-1 Upregulating CXCL10/CXCL8 Expression in High-Glucose Endothelial Cells by Sponging MicroRNAs
Indoxyl Sulfate Elevated Lnc-SLC15A1-1 Upregulating CXCL10/CXCL8 Expression in High-Glucose Endothelial Cells by Sponging MicroRNAs
Material Type:
Article 		Add to My Research

Indoxyl Sulfate Elevated Lnc-SLC15A1-1 Upregulating CXCL10/CXCL8 Expression in High-Glucose Endothelial Cells by Sponging MicroRNAs

Toxins, 2021-12, Vol.13 (12), p.873 [Peer Reviewed Journal]

2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2072-6651 ;EISSN: 2072-6651 ;DOI: 10.3390/toxins13120873 ;PMID: 34941711

Full text available

Citations Cited by
12
Incidence of cardiovascular disease and mortality in underweight individuals
Incidence of cardiovascular disease and mortality in underweight individuals
Material Type:
Article 		Add to My Research

Incidence of cardiovascular disease and mortality in underweight individuals

Journal of cachexia, sarcopenia and muscle, 2021-04, Vol.12 (2), p.331-338 [Peer Reviewed Journal]

2021 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders ;2021 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders. ;2021. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2190-5991 ;EISSN: 2190-6009 ;DOI: 10.1002/jcsm.12682 ;PMID: 33619889

Full text available

Citations Cited by
13
Sodium-Glucose Cotransporter 2 Inhibitors to Decrease the Uric Acid Concentration-A Novel Mechanism of Action
Sodium-Glucose Cotransporter 2 Inhibitors to Decrease the Uric Acid Concentration-A Novel Mechanism of Action
Material Type:
Article 		Add to My Research

Sodium-Glucose Cotransporter 2 Inhibitors to Decrease the Uric Acid Concentration-A Novel Mechanism of Action

Journal of cardiovascular development and disease, 2023-06, Vol.10 (7), p.268 [Peer Reviewed Journal]

COPYRIGHT 2023 MDPI AG ;2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 by the authors. 2023 ;ISSN: 2308-3425 ;EISSN: 2308-3425 ;DOI: 10.3390/jcdd10070268 ;PMID: 37504524

Full text available

Citations Cited by
14
Lipid Testing Trends in the US Before and After the Release of the 2013 Cholesterol Treatment Guidelines
Lipid Testing Trends in the US Before and After the Release of the 2013 Cholesterol Treatment Guidelines
Material Type:
Article 		Add to My Research

Lipid Testing Trends in the US Before and After the Release of the 2013 Cholesterol Treatment Guidelines

Clinical epidemiology, 2020-01, Vol.12, p.835-845 [Peer Reviewed Journal]

2020 Levintow et al. ;COPYRIGHT 2020 Dove Medical Press Limited ;COPYRIGHT 2020 Dove Medical Press Limited ;2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Levintow et al. 2020 Levintow et al. ;ISSN: 1179-1349 ;EISSN: 1179-1349 ;DOI: 10.2147/CLEP.S259757 ;PMID: 32801921

Full text available

Citations Cited by
15
Early Chronic Kidney Disease (G1-G3a) in Combination with Steatosis as a Predictor of Incident Ischemic Heart Disease: A Longitudinal Study in Non-Diabetic Koreans
Early Chronic Kidney Disease (G1-G3a) in Combination with Steatosis as a Predictor of Incident Ischemic Heart Disease: A Longitudinal Study in Non-Diabetic Koreans
Material Type:
Article 		Add to My Research

Early Chronic Kidney Disease (G1-G3a) in Combination with Steatosis as a Predictor of Incident Ischemic Heart Disease: A Longitudinal Study in Non-Diabetic Koreans

Biomedicines, 2021-09, Vol.9 (10), p.1358 [Peer Reviewed Journal]

2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2227-9059 ;EISSN: 2227-9059 ;DOI: 10.3390/biomedicines9101358 ;PMID: 34680475

Full text available

Citations Cited by
16
Understanding Self-Guided Web-Based Educational Interventions for Patients With Chronic Health Conditions: Systematic Review of Intervention Features and Adherence
Understanding Self-Guided Web-Based Educational Interventions for Patients With Chronic Health Conditions: Systematic Review of Intervention Features and Adherence
Material Type:
Article 		Add to My Research

Understanding Self-Guided Web-Based Educational Interventions for Patients With Chronic Health Conditions: Systematic Review of Intervention Features and Adherence

Journal of medical Internet research, 2020-08, Vol.22 (8), p.e18355-e18355 [Peer Reviewed Journal]

Li Feng Xie, Alexandra Itzkovitz, Amelie Roy-Fleming, Deborah Da Costa, Anne-Sophie Brazeau. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 13.08.2020. ;2020. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Li Feng Xie, Alexandra Itzkovitz, Amelie Roy-Fleming, Deborah Da Costa, Anne-Sophie Brazeau. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 13.08.2020. 2020 ;ISSN: 1438-8871 ;ISSN: 1439-4456 ;EISSN: 1438-8871 ;DOI: 10.2196/18355 ;PMID: 32788152

Full text available

Citations Cited by
17
Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study
Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study
Material Type:
Article 		Add to My Research

Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study

Diabetes, obesity & metabolism, 2020-09, Vol.22 (9), p.1607

info:eu-repo/semantics/openAccess ;ISSN: 1462-8902 ;ISSN: 1463-1326 ;EISSN: 1463-1326 ;DOI: 10.1111/dom.14074

Digital Resources/Online E-Resources

Citations Cited by
18
Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury
Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury
Material Type:
Article 		Add to My Research

Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury

Cardiovascular diabetology, 2018-07, Vol.17 (1), p.108-108, Article 108 [Peer Reviewed Journal]

Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2018 ;ISSN: 1475-2840 ;EISSN: 1475-2840 ;DOI: 10.1186/s12933-018-0750-8 ;PMID: 30060748

Full text available

Citations Cited by
19
Prediction of Cardiovascular and All-Cause Mortality After Myocardial Infarction in US Veterans
Prediction of Cardiovascular and All-Cause Mortality After Myocardial Infarction in US Veterans
Material Type:
Article 		Add to My Research

Prediction of Cardiovascular and All-Cause Mortality After Myocardial Infarction in US Veterans

The American journal of cardiology, 2022-04, Vol.169, p.10-17 [Peer Reviewed Journal]

2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;2021. Elsevier Inc. ;ISSN: 0002-9149 ;EISSN: 1879-1913 ;DOI: 10.1016/j.amjcard.2021.12.036 ;PMID: 35063273

Full text available

Citations Cited by
20
Sodium-Glucose Cotransporter-2 Inhibitors in Vascular Biology: Cellular and Molecular Mechanisms
Sodium-Glucose Cotransporter-2 Inhibitors in Vascular Biology: Cellular and Molecular Mechanisms
Material Type:
Article 		Add to My Research

Sodium-Glucose Cotransporter-2 Inhibitors in Vascular Biology: Cellular and Molecular Mechanisms

Cardiovascular drugs and therapy, 2021-12, Vol.35 (6), p.1253-1267 [Peer Reviewed Journal]

Springer Science+Business Media, LLC, part of Springer Nature 2021 ;2021. Springer Science+Business Media, LLC, part of Springer Nature. ;Springer Science+Business Media, LLC, part of Springer Nature 2021. ;ISSN: 0920-3206 ;EISSN: 1573-7241 ;DOI: 10.1007/s10557-021-07216-9 ;PMID: 34273091

Full text available

Citations Cited by

Results 1 - 20 of 23  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (21)

Refine My Results

Creation Date 

From To
Refine
  1. Before 2012  (2)
  2. 2012 To 2017  (3)
  3. 2018 To 2019  (3)
  4. 2020 To 2022  (10)
  5. After 2022  (7)
  6. More options open sub menu

Resource Type 

  1. Articles  (22)
  2. Books  (1)
  3. More options open sub menu

Language 

  1. Japanese  (5)
  2. Norwegian  (1)
  3. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait